Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Carolina Brewery Celebrates 30 Years
Few Tar Heels have a pedigree as lengthy as Robert Poitras, a fourth-generation UNC alum who grew up tailgating at Kenan Stadium and cheering on...
Sun Nov 9, 2025

Meet 10 Tar Heel military heroes
UNC has a longstanding history of supporting veterans on campus. Before or after they served their country, they spent time in Chapel Hill learning from...
Sat Nov 8, 2025

Video: IC Podcast - Touch 'Em All with Larry Keith
"Touch 'Em All: My Life and Career at Sports Illustrated" is Larry Keith's memoir about an accomplished writer and editor who began his career at...
Wed Nov 5, 2025

A guide to Chapel Hill's live music scene
Chapel Hill’s live music scene is bustling and evergreen. Music venues in Chapel Hill and Carrboro have shows almost every single night. Student musicians make...
Wed Nov 5, 2025